Search research articles
Contact Us
Filters
Showing results (171-180 of 287) with videos related to
Page
of 29
Sort By:
BMJ Open
|
December 29, 2022
Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
Mats Steinholtz Ahlberg, Hans Garmo, Hans-Olov Adami, et al.
British Journal of Haematology
|
July 14, 2007
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
Minola Manea, AnnCharlotte Kristoffersson, Reinhard Schneppenheim, et al.
The Lancet. Oncology
|
April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Epidemiology (Cambridge, Mass.)
|
May 3, 2021
An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts
Rolf Gedeborg, Malin Sund, Mats Lambe, et al.
Ecancermedicalscience
|
February 20, 2018
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
Danielle Crawley, Florence Chamberlain, Hans Garmo, et al.
BJU International
|
January 15, 2019
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, et al.
BMC Molecular and Cell Biology
|
July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
Aida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
Gut
|
October 23, 2012
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008
Victoria H Coupland, Jesper Lagergren, Margreet Lüchtenborg, et al.
British Journal of Cancer
|
October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosis
Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 287) with videos related to
Sort By:
Page
of 29
BMJ Open
|
December 29, 2022
Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
Mats Steinholtz Ahlberg, Hans Garmo, Hans-Olov Adami, et al.
British Journal of Haematology
|
July 14, 2007
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
Minola Manea, AnnCharlotte Kristoffersson, Reinhard Schneppenheim, et al.
The Lancet. Oncology
|
April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Epidemiology (Cambridge, Mass.)
|
May 3, 2021
An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts
Rolf Gedeborg, Malin Sund, Mats Lambe, et al.
Ecancermedicalscience
|
February 20, 2018
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
Danielle Crawley, Florence Chamberlain, Hans Garmo, et al.
BJU International
|
January 15, 2019
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, et al.
BMC Molecular and Cell Biology
|
July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
Aida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
Gut
|
October 23, 2012
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008
Victoria H Coupland, Jesper Lagergren, Margreet Lüchtenborg, et al.
British Journal of Cancer
|
October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosis
Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Page
of 29